In particular, high expression of Nucleoporin 43 (NUP43), one of the top downregulated genes in our study, is associated with DNA amplification and poor overall survival in luminal A and HER2+ breast cancer tumors [45]. The gene discussed is ERBB2; the disease is breast carcinoma.